Genetic Study of Schizophrenia
NCT00001486 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4914
Last updated 2026-05-22
Summary
This large ongoing study at NIMH investigates the neurobiology of schizophrenia by identifying susceptibility genes, evaluating their impact on brain function to better understand how to treat and prevent this illness.
Conditions
- Schizoaffective Disorder
- Schizophrenia
Sponsors & Collaborators
-
National Institutes of Health Clinical Center (CC)
collaborator NIH -
National Institute of Mental Health (NIMH)
lead NIH
Principal Investigators
-
Karen F Berman, M.D. · National Institute of Mental Health (NIMH)
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1995-07-15
Countries
- United States
Study Locations
More Related Trials
-
Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia
NCT02205437 ·Status: UNKNOWN
-
Schizophrenia and Genetic Counseling
NCT00111202 ·Status: UNKNOWN
-
Family Study in Schizophrenia
NCT00418912 ·Status: UNKNOWN
-
Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States
NCT01425671 ·Status: COMPLETED
-
Genetics of Symptomatology and Treatment Response in Psychotic Major Depression
NCT00691535 ·Status: COMPLETED
-
Familial Schizophrenia and Spectrum Personality Disorders
NCT00666146 ·Status: COMPLETED
-
Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia
NCT01036568 ·Status: COMPLETED
-
Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia
NCT00001198 ·Status: TERMINATED
-
Enhancing the Prospective Prediction of Psychosis
NCT00291200 ·Status: COMPLETED
-
Prospective Studies of the Pathogenesis of Schizophrenia
NCT00877552 ·Status: COMPLETED
-
Schizophrenia Imaging
NCT01655472 ·Status: UNKNOWN ·Phase: NA
-
Developing Clinical Tools to Communicate Genetic Risk for Individuals Who Are Clinical High Risk for Psychosis
NCT04325568 ·Status: COMPLETED ·Phase: PHASE1
-
Translational Investigation of the Glutamatergic and GABAergic System in Schizophrenia
NCT04655235 ·Status: RECRUITING
-
Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers
NCT00001284 ·Status: COMPLETED
-
A Positional Cloning Study on Schizophrenia
NCT00155649 ·Status: COMPLETED
-
Evaluation of the Role of Neurodegeneration in Schizophrenia
NCT05257720 ·Status: COMPLETED
-
Inpatient Evaluation of Adults With Schizophrenia
NCT00001247 ·Status: COMPLETED
-
Evaluating Pharmacogenomics-Based Pharmacotherapy in Real-World Settings for Schizophrenia
NCT06700967 ·Status: NOT_YET_RECRUITING
-
Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia
NCT02964923 ·Status: UNKNOWN
-
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders
NCT03649581 ·Status: RECRUITING ·Phase: NA
-
PhaRmacOgenetics and Therapeutic Drug Monitoring In SchizophrEnia
NCT05839613 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Imaging of Brain Receptors in Healthy Volunteers and in Patients With Schizophrenia
NCT00061789 ·Status: COMPLETED ·Phase: PHASE2
-
Adverse Events and Genomics in Schizophrenia
NCT01966588 ·Status: UNKNOWN
-
Emotion Endophenotypes in Schizophrenia
NCT02834208 ·Status: UNKNOWN ·Phase: NA
-
Biomarkers in First Episode Schizophrenia
NCT02033382 ·Status: COMPLETED